Newsroom
To Get in Touch with DLC:
Media (@) Diabetes Leadership (DOT) org
Hot Topics
Diabetes Leadership Council Calls for Expanded Patient Choice in Diabetes Technologies to Improve Outcomes and Equity
Read MoreLetter
DLC and DPAC are Disappointed in the CMS Decision Not to Extend Obesity Treatment Coverage to Medicare & Medicaid Beneficiaries
Read MoreDLC Brief: Modernize Medicare Coverage for Equitable, Evidence-based Access to Diabetes Technologies
Read MoreIn The News
Patient advocates are bristling
Politico
Hot New Diabetes Technology at the June 2021 DiabetesMine D-Data ExChange
Healthline
To Reduce Prescription Prices, Hold Middlemen Accountable
Law360
Statements and Letters
Fast Facts
Policy Recommendations to Improve U.S. Health Care
Patient costs for medicines, equipment and supplies should reflect all discounts and rebates negotiated or mandated across the supply chain, just like other health care products and services. National level rebate reform is a critical step to help patients afford their medicines and confront perverse financial incentives in the current system.
Download Our Consensus Statement